2021 American Transplant Congress
An Investigation of Surgeon’s Effect on Deceased-Donor Kidney Offers and Transplant Outcomes
Department of Surgery, UCSF, San Francisco, CA
*Purpose: We studied the transplant surgeons' effect on accepting or rejecting the deceased donor kidney offers and their subsequent effect on transplant outcomes.*Methods: There are…2021 American Transplant Congress
The Impact of Living Donors Aged 70 and Older on Living Donor Kidney Transplantation
Nagoya Daini Red Cross Hospital, Nagoya Aichi, Japan
*Purpose: Due to the discrepancy between the number of patients on the waiting list and oragn supply, living donor kidney transplantation is more required. The…2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA in Children with Kidney Transplantation: A Pilot Study
*Purpose: Use of a blood test to detect donor-derived cell-free DNA (dd-cfDNA) levels has been shown to predict rejection in adults with kidney transplants. If…2021 American Transplant Congress
Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race
*Purpose: Kidney transplant [KTx] in recipients with BMI > 35 remains controversial and has not often been studied in recipients with BMI >40. There is…2021 American Transplant Congress
The Impact of 4-weeks of Supervised Exercise on Frailty and Lower Extremity (LE) Function in Patients with Advanced Chronic Kidney Disease (CKD)
*Purpose: Although frailty is a modifiable risk factor for morbidity and mortality among kidney transplant (KT) candidates, the optimal duration of effective prehabilitation interventions is…2021 American Transplant Congress
Efficacy of MAU868, a Novel BKV Neutralizing Monoclonal Antibody (mAb), for the Treatment of Severe BK Virus Nephropathy (BKVN) After Kidney Transplant
*Purpose: BKV reactivation leading to nephropathy and allograft loss in kidney transplant (KT) recipients remains a clinical significant concern. No specific or effective anti-BKV therapies…2021 American Transplant Congress
Versatile Strategy to Enhance Nanomedicine Delivery to Graft Endothelial Cells
*Purpose: Efficient delivery of therapeutics to graft endothelial cells (EC) can potentially render organs more resistant to injury, improving clinical outcomes. Specific targeting of polymeric…2021 American Transplant Congress
Covid vs Non Covid Pneumonia in Kidney Transplant Recipients
Henry Ford Hospital, Detroit, MI
*Purpose: Compare clinical characteristics and outcomes in kidney transplant recipients (KTRs) hospitalized with COVID vs Non COVID Pneumonia.*Methods: This is a retrospective case‐control study examining…2021 American Transplant Congress
The Impact of High Kdpi on 1-year Post-transplant Graft Function and Survival in a Brazilian Cohort
Núcleo de Ensino e Pesquisa, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil
*Purpose: To evaluate the impact of High Kidney Donor Profile Index (KDPI) on 1-year post-transplant renal function and graft survival.*Methods: This retrospective cohort analyzed 3,059…2021 American Transplant Congress
Which Living Kidney Donors Arrive to the Donation Process Informed About Surgery?
Henry Ford Hospital, Detroit, MI
*Purpose: To evaluate perceived knowledge about surgery in potential living kidney donors embarking on the donation process.*Methods: Potential living kidney donors were surveyed about their…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 101
- Next Page »